[Sutimlimab for cold agglutinin disease, a newcomer among complement inhibitors in immunohematology]

M Michel

doi:10.1016/j.revmed.2024.04.444

[Sutimlimab for cold agglutinin disease, a newcomer among complement inhibitors in immunohematology]

Rev Med Interne. 2024 May;45(5):255-257. doi: 10.1016/j.revmed.2024.04.444. Epub 2024 May 7.

[Article in French]

Author

M Michel¹

Affiliation

¹ Service de médecine interne, centre de référence sur les cytopénies auto-immunes de l'adulte, CHU Henri-Mondor, université Paris-Est Créteil, Créteil, France. Electronic address: marc.michel2@aphp.fr.

PMID: 38719668
DOI: 10.1016/j.revmed.2024.04.444

No abstract available

Keywords: Cold agglutinin disease; Complement classical pathway; Complement inhibitor; Inhibition du complément; Maladie des agglutinines froides; Sutimlimab; Voie classique du complément.

Publication types

Case Reports
Editorial

MeSH terms

Anemia, Hemolytic, Autoimmune* / diagnosis
Anemia, Hemolytic, Autoimmune* / drug therapy
Antibodies, Monoclonal, Humanized* / therapeutic use
Complement Inactivating Agents / therapeutic use
Humans

Substances

Antibodies, Monoclonal, Humanized
Complement Inactivating Agents